MeiraGTx
MGTX
6,99 €
Share price
-1.94%
Change (1 day)
53.57%
Change (1 year)
Earnings for MeiraGTx (MGTX)
Earnings in 2025 (TTM): -€0.15 Billion
According to MeiraGTx's latest financial reports the company's current earnings are €34.5 Million. In 2024 the company made an earning of -€0.12 Billion a decrease over its 2023 earnings that were of -€61.27 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for MeiraGTx from 2017 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | -€0.15 Billion | 23.06% |
| 2024 | -€0.12 Billion | 90.05% |
| 2023 | -€61.27 Million | -43.22% |
| 2022 | -€0.11 Billion | 57.27% |
| 2021 | -€68.62 Million | 37.02% |
| 2020 | -€50.08 Million | 5.77% |
| 2019 | -€47.35 Million | -34.34% |
| 2018 | -€72.12 Million | 168.72% |
| 2017 | -€26.84 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Novocure
NVCR | -€0.11 Billion | -24.05% | Jersey |
 Novavax NVAX | €0.44 B | -430.73% | 🇺🇸 USA |
 Organovo ONVO | -€2.16 Million | -98.39% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -€63.25 Million | -52.64% | 🇬🇧 UK |